Neurological Surgery Doctors in Santa Ana, CA Accepting Medicare

4 Neurological Surgery doctors found. Showing 1 - 4

Peyman Tabrizi, Neurological Surgery Medicare: May Accept Medicare Assignments Practice Location: 1220 Hemlock Way Ste 205, Santa Ana, CA 92707 Phone: 714-834-0439    Fax: 714-953-3425

Bijan Zardouz, M.D. Neurological Surgery Medicare: May Accept Medicare Assignments Practice Location: 1220 Hemlock Way, Suite 108, Santa Ana, CA 92707 Phone: 714-540-2272    Fax: 714-540-7206

Andrew O Schreiber, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1535 E 17th St Ste 101, Santa Ana, CA 92705 Phone: 714-834-1565    Fax: 714-834-1551

Dr. M. Mohsin Shah, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 999 N Tustin Ave, Suite 109, Santa Ana, CA 92705 Phone: 949-870-9784    Fax: 949-284-0604

News Archive

Researchers report novel charge zipper principle used by proteins to form functional units

Membrane proteins are the "molecular machines" in biological cell envelopes. They control diverse processes, such as the transport of molecules across the lipid membrane, signal transduction, and photosynthesis. Their shape, i.e. folding of the molecules, plays a decisive role in the formation of, e.g., pores in the cell membrane.

Compelling evidence of SARS-CoV-2 exposure and neutralizing antibodies in domestic cats in Peru

Although Peru is one of the countries most affected by the pandemic, no studies had been conducted to investigate SARS-CoV-2 seroprevalence among domestic cats. Recently, researchers from Peru demonstrated the presence of neutralizing antibodies for the receptor binding-domain (RBD) of the SARS-CoV-2 spike protein in cats in Lima, Peru. The owners of the cats in the study had confirmed SARS-CoV-2 infection.

Eisai signs agreement with Arena Pharmaceuticals GmbH to commercialize lorcaserin

Eisai Inc., the U.S. pharmaceutical operation of Tokyo-based Eisai Co., Ltd., announced today that it has entered into an agreement with Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc., for exclusive U.S. rights to commercialize lorcaserin, a drug candidate for potential use in the treatment of obesity, including weight loss, for patients who are obese (Body Mass Index or BMI ≥ 30) or overweight (BMI ≥ 27) with at least one weight-related co-morbid condition.

Increased consumption of artificial sweeteners and of high-calorie beverages is not the sole cause of obesity, but it may be a contributing factor

Choosing a diet soft drink over a regular, sugar-packed beverage may not be the best way to fight obesity, according to new research from Purdue University.

Study contradicts USA warning that an antidepressant can cause congenital abnormalities

A study carried out by German researchers has failed to show that a popular antidepressant, paroxetine, causes congenital abnormalities if taken by pregnant women, the 22nd annual conference of the European Society of Human Reproduction and Embryology heard.

Read more Medical News

› Verified 9 days ago